Amigla 250mg Injection
Marketer
Gladcare Formulations Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Amigla 250mg Injection
Cefamandole nafate 250mg injection combats a broad spectrum of bacterial infections, encompassing urinary tract, bone and joint, pulmonary (such as pneumonia), cerebral, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized individuals. This antibiotic functions by inhibiting bacterial proliferation. Administration, either intravenously or intramuscularly, requires medical oversight; self-administration is strictly prohibited. Adherence to the prescribed dosage regimen, with evenly spaced intervals, is crucial. Premature cessation may result in relapse or infection exacerbation. Typical adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High-dose therapy may induce vestibular disturbances (dizziness), nephrotoxicity, and ototoxicity. Therefore, diligent adherence to physician instructions is paramount, potentially including regular monitoring of renal function, auditory acuity, and urinalysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Primary Ingredients of Amigla 250mg Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Amigla 250mg Injection
Infections caused by bacteria
Major Benefits of Amigla 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Amigla 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Amigla 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Amigla 250mg Injection works:
Amigla 250mg Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Amigla 250mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Amigla 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Amigla 250mg poses no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
The administration of Amigla 250mg Injection can potentially reduce awareness, impair visual acuity, and induce drowsiness or vertigo. Driving should be avoided if such effects manifest.
KidneyCAUTION
For individuals with kidney impairment, Amigla 250mg Injection requires careful administration. Dosage modification of Amigla 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Amigla 250mg Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Amigla 250mg Injection :
Omit Amigla 250mg Injection doses only after physician consultation.
Facts to Know About Amigla 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently